Preliminary Results of High-Dose Chemotherapy in Primary Breast Cancer Show Equivalency to Intermediate-Dose Treatment; 3 Years of Additional Follow-up Required

University of Pennsylvania Cancer Center
Ultima Vez Modificado: 17 de mayo del 1999

Translation for this article does not exist